Last 12 months
Inside the activity.
0 purchase rows · 17 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 17, 2022 Filed May 19, 2022 20:40 UTC |
Buller Richard EDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 4,555 | Not disclosed Strike: $10.68 | Not disclosed |
DisclosureSEC source: 0001437749-22-013129 · rdgdoc.xml · derivative · entry 2 Buller Richard E · CIK 0001688319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,555 shares Expires 2029-12-03 F4 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F2 · derivative.exercise_date: 100% vested. Read SEC document |
| May 17, 2022 Filed May 19, 2022 20:40 UTC |
Buller Richard EDirector
|
GrantCommon Stock | 3,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-013129 · rdgdoc.xml · nonDerivative · entry 1 Buller Richard E · CIK 0001688319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,798 F1 · shares: Represents 3,273 shares of restricted stock for which risks of forfeiture lapse on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:41 UTC |
Dalvey DavidDirector
|
GrantStock Option (right to buy) · Derivative | 24,449 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001437749-22-013130 · rdgdoc.xml · derivative · entry 12 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,449 Underlying: Common Stock · 24,449 shares Expires 2032-05-17 F4 · derivative.exercise_date: This Option will vest and become exercisable on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:41 UTC |
Dalvey DavidDirector
|
GrantStock Option (right to buy) · Derivative | 2,310 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013130 · rdgdoc.xml · derivative · entry 11 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,310 Underlying: Common Stock · 2,310 shares Expires 2031-05-12 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F2 · derivative.exercise_date: 100% vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:41 UTC |
Dalvey DavidDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 2,310 | Not disclosed Strike: $26.99 | Not disclosed |
DisclosureSEC source: 0001437749-22-013130 · rdgdoc.xml · derivative · entry 10 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,310 shares Expires 2031-05-12 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F2 · derivative.exercise_date: 100% vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:41 UTC |
Dalvey DavidDirector
|
GrantStock Option (right to buy) · Derivative | 5,054 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013130 · rdgdoc.xml · derivative · entry 8 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,054 Underlying: Common Stock · 5,054 shares Expires 2029-05-16 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F2 · derivative.exercise_date: 100% vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:41 UTC |
Dalvey DavidDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 5,054 | Not disclosed Strike: $22.45 | Not disclosed |
DisclosureSEC source: 0001437749-22-013130 · rdgdoc.xml · derivative · entry 7 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,054 shares Expires 2029-05-16 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F2 · derivative.exercise_date: 100% vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:41 UTC |
Dalvey DavidDirector
|
GrantStock Option (right to buy) · Derivative | 3,201 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013130 · rdgdoc.xml · derivative · entry 6 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,201 Underlying: Common Stock · 3,201 shares Expires 2028-05-14 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F2 · derivative.exercise_date: 100% vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:41 UTC |
Dalvey DavidDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 3,201 | Not disclosed Strike: $19.45 | Not disclosed |
DisclosureSEC source: 0001437749-22-013130 · rdgdoc.xml · derivative · entry 5 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2028-05-14 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F2 · derivative.exercise_date: 100% vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:41 UTC |
Dalvey DavidDirector
|
GrantStock Option (right to buy) · Derivative | 8,200 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013130 · rdgdoc.xml · derivative · entry 4 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,200 Underlying: Common Stock · 8,200 shares Expires 2027-10-19 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F2 · derivative.exercise_date: 100% vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:41 UTC |
Dalvey DavidDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 8,200 | Not disclosed Strike: $16.23 | Not disclosed |
DisclosureSEC source: 0001437749-22-013130 · rdgdoc.xml · derivative · entry 3 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,200 shares Expires 2027-10-19 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F2 · derivative.exercise_date: 100% vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:43 UTC |
NIGON RICHARDDirector
|
GrantStock Option (right to buy) · Derivative | 24,449 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001437749-22-013132 · rdgdoc.xml · derivative · entry 17 NIGON RICHARD · CIK 0001213869 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,449 Underlying: Common Stock · 24,449 shares Expires 2032-05-17 F3 · derivative.exercise_date: This Option will vest and become exercisable on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:43 UTC |
NIGON RICHARDDirector
|
GrantStock Option (right to buy) · Derivative | 4,619 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013132 · rdgdoc.xml · derivative · entry 11 NIGON RICHARD · CIK 0001213869 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,619 Underlying: Common Stock · 4,619 shares Expires 2031-05-12 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Currently exercisable. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:43 UTC |
NIGON RICHARDDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 4,619 | Not disclosed Strike: $26.99 | Not disclosed |
DisclosureSEC source: 0001437749-22-013132 · rdgdoc.xml · derivative · entry 10 NIGON RICHARD · CIK 0001213869 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,619 shares Expires 2031-05-12 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Currently exercisable. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:43 UTC |
NIGON RICHARDDirector
|
GrantStock Option (right to buy) · Derivative | 5,054 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013132 · rdgdoc.xml · derivative · entry 8 NIGON RICHARD · CIK 0001213869 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,054 Underlying: Common Stock · 5,054 shares Expires 2029-05-16 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Currently exercisable. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:43 UTC |
NIGON RICHARDDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 5,054 | Not disclosed Strike: $22.45 | Not disclosed |
DisclosureSEC source: 0001437749-22-013132 · rdgdoc.xml · derivative · entry 7 NIGON RICHARD · CIK 0001213869 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,054 shares Expires 2029-05-16 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Currently exercisable. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:43 UTC |
NIGON RICHARDDirector
|
GrantStock Option (right to buy) · Derivative | 3,201 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013132 · rdgdoc.xml · derivative · entry 6 NIGON RICHARD · CIK 0001213869 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,201 Underlying: Common Stock · 3,201 shares Expires 2028-05-14 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Currently exercisable. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:43 UTC |
NIGON RICHARDDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 3,201 | Not disclosed Strike: $19.45 | Not disclosed |
DisclosureSEC source: 0001437749-22-013132 · rdgdoc.xml · derivative · entry 5 NIGON RICHARD · CIK 0001213869 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,201 shares Expires 2028-05-14 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Currently exercisable. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:43 UTC |
NIGON RICHARDDirector
|
GrantStock Option (right to buy) · Derivative | 8,200 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013132 · rdgdoc.xml · derivative · entry 4 NIGON RICHARD · CIK 0001213869 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,200 Underlying: Common Stock · 8,200 shares Expires 2027-10-19 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Currently exercisable. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:43 UTC |
NIGON RICHARDDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 8,200 | Not disclosed Strike: $16.23 | Not disclosed |
DisclosureSEC source: 0001437749-22-013132 · rdgdoc.xml · derivative · entry 3 NIGON RICHARD · CIK 0001213869 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,200 shares Expires 2027-10-19 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Currently exercisable. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:42 UTC |
Furcht LeoDirector
|
GrantStock Option (right to buy) · Derivative | 24,449 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001437749-22-013131 · rdgdoc.xml · derivative · entry 15 Furcht Leo · CIK 0001775749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,449 Underlying: Common Stock · 24,449 shares Expires 2032-05-17 F3 · derivative.exercise_date: This Option will vest and become exercisable on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:42 UTC |
Furcht LeoDirector
|
GrantStock Option (right to buy) · Derivative | 4,619 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013131 · rdgdoc.xml · derivative · entry 14 Furcht Leo · CIK 0001775749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,619 Underlying: Common Stock · 4,619 shares Expires 2031-05-12 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:42 UTC |
Furcht LeoDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 4,619 | Not disclosed Strike: $26.99 | Not disclosed |
DisclosureSEC source: 0001437749-22-013131 · rdgdoc.xml · derivative · entry 13 Furcht Leo · CIK 0001775749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,619 shares Expires 2031-05-12 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:42 UTC |
Furcht LeoDirector
|
GrantStock Option (right to buy) · Derivative | 5,054 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013131 · rdgdoc.xml · derivative · entry 11 Furcht Leo · CIK 0001775749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,054 Underlying: Common Stock · 5,054 shares Expires 2029-05-16 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:42 UTC |
Furcht LeoDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 5,054 | Not disclosed Strike: $22.45 | Not disclosed |
DisclosureSEC source: 0001437749-22-013131 · rdgdoc.xml · derivative · entry 10 Furcht Leo · CIK 0001775749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,054 shares Expires 2029-05-16 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:42 UTC |
Furcht LeoDirector
|
GrantStock Option (right to buy) · Derivative | 500 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013131 · rdgdoc.xml · derivative · entry 9 Furcht Leo · CIK 0001775749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock · 500 shares Expires 2028-12-31 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:42 UTC |
Furcht LeoDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 500 | Not disclosed Strike: $23.99 | Not disclosed |
DisclosureSEC source: 0001437749-22-013131 · rdgdoc.xml · derivative · entry 8 Furcht Leo · CIK 0001775749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500 shares Expires 2028-12-31 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:42 UTC |
Furcht LeoDirector
|
GrantStock Option (right to buy) · Derivative | 500 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013131 · rdgdoc.xml · derivative · entry 7 Furcht Leo · CIK 0001775749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock · 500 shares Expires 2027-12-29 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:42 UTC |
Furcht LeoDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 500 | Not disclosed Strike: $18.95 | Not disclosed |
DisclosureSEC source: 0001437749-22-013131 · rdgdoc.xml · derivative · entry 6 Furcht Leo · CIK 0001775749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500 shares Expires 2027-12-29 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC |
Hahne VickyChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 31,930 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 22 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,930 Underlying: Common Stock · 31,930 shares Expires 2032-05-17 F13 · derivative.exercise_date: These shares vest in equal amounts over fourteen (14) months, beginning June 1, 2022. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC |
Hahne VickyChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 821 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 21 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 821 Underlying: Common Stock · 821 shares Expires 2031-10-27 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F12 · derivative.exercise_date: 205 shares vest on 10/27/22; the remaining 616 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC |
Hahne VickyChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 821 | Not disclosed Strike: $17.19 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 20 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 821 shares Expires 2031-10-27 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F12 · derivative.exercise_date: 205 shares vest on 10/27/22; the remaining 616 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC |
Hahne VickyChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 19 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-08-11 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F11 · derivative.exercise_date: 3,750 shares vest on 8/11/22; the remaining 11,250 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC |
Hahne VickyChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $20.04 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 18 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2031-08-11 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F11 · derivative.exercise_date: 3,750 shares vest on 8/11/22; the remaining 11,250 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC |
Hahne VickyChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 3,806 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 17 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,806 Underlying: Common Stock · 3,806 shares Expires 2031-04-12 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F10 · derivative.exercise_date: 952 shares vest on 4/12/22; the remaining 2,854 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC |
Hahne VickyChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 3,806 | Not disclosed Strike: $27.94 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 16 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,806 shares Expires 2031-04-12 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F10 · derivative.exercise_date: 952 shares vest on 4/12/22; the remaining 2,854 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC |
Hahne VickyChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 1,204 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 15 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,204 Underlying: Common Stock · 1,204 shares Expires 2031-03-18 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F9 · derivative.exercise_date: 301 shares vest on 3/18/22; the remaining 903 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC |
Hahne VickyChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 1,204 | Not disclosed Strike: $15.92 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 14 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,204 shares Expires 2031-03-18 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F9 · derivative.exercise_date: 301 shares vest on 3/18/22; the remaining 903 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC |
Hahne VickyChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 1,301 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 13 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,301 Underlying: Common Stock · 1,301 shares Expires 2031-02-02 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F8 · derivative.exercise_date: 325 shares vest on 2/2/22; the remaining 976 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC |
Hahne VickyChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 1,301 | Not disclosed Strike: $14.84 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 12 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,301 shares Expires 2031-02-02 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F8 · derivative.exercise_date: 325 shares vest on 2/2/22; the remaining 976 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC |
Hahne VickyChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 1,122 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 11 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,122 Underlying: Common Stock · 1,122 shares Expires 2030-12-28 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F7 · derivative.exercise_date: 280 shares vest on 12/29/21; the remaining 842 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC |
Hahne VickyChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 1,122 | Not disclosed Strike: $10.35 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 10 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,122 shares Expires 2030-12-28 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F7 · derivative.exercise_date: 280 shares vest on 12/29/21; the remaining 842 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC |
Hahne VickyChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 3,000 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 8 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2029-08-12 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F5 · derivative.exercise_date: 750 shares vest on 8/12/20; the remaining 2,250 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC |
Hahne VickyChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 3,000 | Not disclosed Strike: $19.72 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 7 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2029-08-12 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F5 · derivative.exercise_date: 750 shares vest on 8/12/20; the remaining 2,250 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC |
Hahne VickyChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 932 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 6 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 932 Underlying: Common Stock · 932 shares Expires 2028-10-17 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F4 · derivative.exercise_date: 233 shares vest on 10/17/19; the remaining 699 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC |
Hahne VickyChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 932 | Not disclosed Strike: $25.77 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 5 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 932 shares Expires 2028-10-17 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F4 · derivative.exercise_date: 233 shares vest on 10/17/19; the remaining 699 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC |
Hahne VickyChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 3,000 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 4 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2028-07-05 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F3 · derivative.exercise_date: 750 shares vest on 7/5/19; the remaining 2,250 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC |
Hahne VickyChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 3,000 | Not disclosed Strike: $23.48 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 3 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2028-07-05 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F3 · derivative.exercise_date: 750 shares vest on 7/5/19; the remaining 2,250 shares vest 1/36th per month thereafter. Read SEC document |
| May 15, 2022 Filed May 17, 2022 21:11 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
PurchaseWarrants (right to buy) · Derivative | 10,434 | $0.00 Strike: $80.50 | $0.00 |
DisclosureSEC source: 0001437749-22-012833 · rdgdoc.xml · derivative · entry 3 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,434 Underlying: Series A Preferred Stock · 10,434 shares Expires not disclosed F1 · shares: Represents the right to acquire the security pursuant to a securities purchase agreement entered into with the Company on May 15, 2022. F1 · derivative.exercise_date: Represents the right to acquire the security pursuant to a securities purchase agreement entered into with the Company on May 15, 2022. F1 · derivative.expiration_date: Represents the right to acquire the security pursuant to a securities purchase agreement entered into with the Company on May 15, 2022. Read SEC document |
| May 15, 2022 Filed May 17, 2022 21:11 UTC |
Sullivan Brian F.Director · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock (right to buy) · Derivative | 260,869 | $0.00 Strike: $5.75 | $0.00 |
DisclosureSEC source: 0001437749-22-012833 · rdgdoc.xml · derivative · entry 2 Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,869 Underlying: Common Stock · 260,869 shares Expires not disclosed F1 · shares: Represents the right to acquire the security pursuant to a securities purchase agreement entered into with the Company on May 15, 2022. F1 · derivative.exercise_date: Represents the right to acquire the security pursuant to a securities purchase agreement entered into with the Company on May 15, 2022. F1 · derivative.expiration_date: Represents the right to acquire the security pursuant to a securities purchase agreement entered into with the Company on May 15, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.